The US Patent and Trademark Office has issued US patent number 10,279,179 titled “Transcutaneous Electrical Nerve Stimulator with automatic detection of user sleep-wake state” to NeuroMetrix Inc. The patent covers technology that automatically adapts electrical stimulation to the user’s sleep pattern. NeuroMetrix now has 11 issued US utility patents covering Quell Wearable Pain Relief Technology™.

“We are pleased to have received this latest patent, which describes a unique on-demand overnight therapy option for chronic pain sufferers using Quell,” says Shai N. Gozani, MD, PhD, president and CEO of NeuroMetrix, in a release. “We are continually improving Quell therapy options available to our users overnight because many report that pain interferes with their sleep. Quell is the only wearable transcutaneous electrical nerve stimulator that is cleared by the FDA for overnight use.”